CVS Health
CVS
1,600 hedge funds and large institutions have $68.8B invested in CVS Health in 2018 Q3 according to their latest regulatory filings, with 140 funds opening new positions, 647 increasing their positions, 652 reducing their positions, and 99 closing their positions.
65% more funds holding in top 10
Funds holding in top 10: 48 → 79 (+31)
41% more first-time investments, than exits
New positions opened: 140 | Existing positions closed: 99
25% more capital invested
Capital invested by funds: $55B → $68.8B (+$13.8B)
22% more call options, than puts
Call options by funds: $1.29B | Put options by funds: $1.05B
1.78% more ownership
Funds ownership: 84.15% → 85.94% (+1.8%)
2% more funds holding
Funds holding: 1,573 → 1,600 (+27)
1% less repeat investments, than reductions
Existing positions increased: 647 | Existing positions reduced: 652
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$1.08B |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$643M |
| 3 |
Diamond Hill Capital Management
Columbus,
Ohio
|
+$186M |
| 4 |
Lazard Asset Management
New York
|
+$160M |
| 5 |
BlackRock
New York
|
+$147M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$541M |
| 2 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
-$265M |
| 3 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
-$247M |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
-$173M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$166M |
CVS Hedge Fund Activity: Q3 2018 in Review
1,600 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2018, worth a combined $68.8B — up 25% from $55B a quarter earlier.
Buyers outnumbered sellers: 140 funds opened new CVS positions and 99 closed out — a net gain of 41 holders — while 647 added to existing stakes and 652 trimmed.
The largest buyer was Dodge & Cox, opening a new position worth an estimated $1.08B. The largest seller was Capital World Investors, exiting entirely with an estimated $541M sold.
- 1,600 institutional investors held CVS Health (CVS) as of Q3 2018, up from 1,573 in Q2 2018.
- Funds reported $68.8B of CVS Health stock for Q3 2018, up 25% quarter-over-quarter.
- 140 funds opened new CVS Health positions in Q3 2018 and 99 closed out, a net change of +41 holders.
- The largest CVS Health buyer in Q3 2018 was Dodge & Cox, an estimated $1.08B added.
- The largest CVS Health seller in Q3 2018 was Capital World Investors, an estimated $541M sold.
Based on aggregated 13F filings for Q3 2018.